Anti-Neurogranin (NRGN) Monoclonal Antibody Homo sapiens (Human) Protein, Antibody, Assaykit, Service

Ng; NEUG; Protein Kinase C Substrate RC3

Add to Cart Distributors
Overview
Properties
  • Ig Isotype IgG, Clone Number n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Excitation Laser
  • Vol. per test
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Anti-Neurogranin (NRGN) Monoclonal Antibody Packages (Simulation)
  • Anti-Neurogranin (NRGN) Monoclonal Antibody Packages (Simulation)
  • Anti-Neurogranin (NRGN) Monoclonal Antibody Human THP1 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10µg/ml mouse Anti-human NRGN Monoclonal Antibody (Catalog FAA404Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Usage

Flow cytometry: 10µg/ml;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Giveaways

Citations

  • Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profilePubmed:27408937
  • Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal agingPubmed:27231710
  • Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer’s diseasepubmed:27601437
  • Growth Hormone-Releasing Hormone Administration in Mild Cognitive Impairment and Its Impact on Neuronal Exosome Biomarkers of DementiaDoi: 10.3233/JAD-180302
  • SYNAPTIC PROTEIN BIOMARKERS AND DIFFERENTIAL DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
  • The diagnostic value of neurogranin in patients with carbon monoxide poisoning: Can it show early neurological damage?34388687

Recommend products